| Combination of Interferon-gamma and Nivolumab for Advanced Solid Tumors (NCT02614456) | Fox Chase Cancer Center | 2015-12-11 |
| A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors (NCT02564198) | Eli Lilly and Company | 2015-12-11 |
| KPT-330 Plus RICE for Relapsed/Refractory Aggressive B-Cell Lymphoma (NCT02471911) | Weill Medical College of Cornell University | 2015-12-11 |
| A Study of LY3090106 in Participants With Sjögren's Syndrome (SS) (NCT02614716) | Eli Lilly and Company | 2015-12-10 |
| The Effectiveness of Topical Silver Colloid in Treating Patients With Recalcitrant Chronic Rhinosinusitis (NCT02403479) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-12-10 |
| A DDI Study to Assess the Effect of INC280 on the PK of Midazolam and Caffeine in Patients With cMET-dysregulated Advanced Solid Tumors (NCT02520752) | Novartis Pharmaceuticals | 2015-12-10 |
| Safety & Immunogenicity of JNJ-64041809, a Live Attenuated Double-deleted Listeria Immunotherapy, in Participants With Metastatic Castration-resistant Prostate Cancer (NCT02625857) | Janssen Research & Development, LLC | 2015-12-10 |
| A Multiple-ascending-dose Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of MEDI0382 in Overweight and Obese Participants With Type 2 Diabetes Mellitus (NCT02548585) | MedImmune LLC | 2015-12-09 |
| Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali (NCT02627456) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-12-09 |
| Hyperpolarized Imaging in Diagnosing Participants With Glioma (NCT03739411) | Susan Chang | 2015-12-09 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GS-5829 (Alobresib) as a Single Agent and In Combination With Enzalutamide in Participants With Metastatic Castrate-Resistant Prostate Cancer (NCT02607228) | Gilead Sciences | 2015-12-08 |
| A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors (NCT02626234) | Novartis Pharmaceuticals | 2015-12-08 |
| Phase I/II, Study of Selective Inhibitor of Nuclear Export (SINE) Selinexor (KPT-330) + Sorafenib in Acute Myeloid Leukemia (NCT02530476) | M.D. Anderson Cancer Center | 2015-12-08 |
| Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Dystrophic Epidermolysis Bullosa (NCT02579369) | Anterogen Co., Ltd. | 2015-12-08 |
| NIR Fluorescence Imaging of Lymphatic Transport Using ICG (NCT02680067) | University of Rochester | 2015-12-08 |
| A Study to Assess the Safety and Immunogenicity of a Malaria Vaccine Candidate, R21, Administered With AS01B (NCT02600975) | University of Oxford | 2015-12-08 |
| Phase 1 Safety and Tolerability Study of Andes-1537 for Injection in Patients With Advanced Unresectable Solid Tumors (NCT02508441) | Andes Biotechnologies | 2015-12-08 |
| A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal Cancer (NCT02613221) | Takeda | 2015-12-07 |
| A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C) (NCT02627274) | Hoffmann-La Roche | 2015-12-07 |
| A Phase 2a to Evaluate the Safety of MEDI8852 in Adults With Uncomplicated Influenza (NCT02603952) | MedImmune LLC | 2015-12-07 |
| Study of AZD2014 and Palbociclib in Patients With Estrogen Receptor Positive (ER+) Metastatic Breast Cancer (NCT02599714) | AstraZeneca | 2015-12-07 |
| A Study to Characterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple Sclerosis (NCT02583594) | Genzyme, a Sanofi Company | 2015-12-06 |
| A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection (NCT02593851) | Janssen Sciences Ireland UC | 2015-12-04 |
| Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib (NCT02621047) | Hoffmann-La Roche | 2015-12-04 |
| First Time in Human (FTIH) Study of GSK3008348 in Healthy Volunteers and Idiopathic Pulmonary Fibrosis Patients (NCT02612051) | GlaxoSmithKline | 2015-12-04 |
| A Study to Assess the Effects of Renal Impairment on the Pharmacokinetics, Safety, and Tolerability of Intranasally Administered Esketamine (NCT02606084) | Janssen Research & Development, LLC | 2015-12-04 |
| MDCO-216 Infusions Leading to Changes in Atherosclerosis: A Novel Therapy in Development to Improve Cardiovascular Outcomes - Proof of Concept Intravascular Ultrasound (IVUS), Lipids, and Other Surrogate Biomarkers Trial (NCT02678923) | The Medicines Company | 2015-12-03 |
| Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma (NCT02510950) | Washington University School of Medicine | 2015-12-03 |
| MPDL3280A and Stereotactic Ablative Radiotherapy in Patients With Non-small Cell Lung Cancer (NCT02400814) | Megan Daly, MD | 2015-12-03 |
| A Study in Healthy Volunteers to Evaluate the Pharmacokinetic Food Effect and Cardiac Safety of CCX168 (NCT05988021) | Amgen | 2015-12-03 |
| A Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid Tumors (NCT02605083) | Effector Therapeutics | 2015-12-03 |
| MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian Cancer (NCT02582931) | Washington University School of Medicine | 2015-12-02 |
| Safety, Pharmacokinetics and Pharmacodynamics of BMS-936559 in Severe Sepsis (NCT02576457) | Bristol-Myers Squibb | 2015-12-02 |
| A Study of Mirikizumab (LY3074828) in Healthy Participants (NCT02568423) | Eli Lilly and Company | 2015-12-02 |
| Study of an Investigational Drug, RO7239361 (BMS-986089), in Ambulatory Boys With DMD (NCT02515669) | Hoffmann-La Roche | 2015-12-02 |
| Safety & Immunogenicity of JNJ-64041757, Live-attenuated Double-deleted Listeria Immunotherapy, in Subjects With Non Small Cell Lung Cancer (NCT02592967) | Janssen Research & Development, LLC | 2015-12-02 |
| Phase 1/2 Study of Motolimod, Doxorubicin, and Durvalumab in Recurrent, Platinum-Resistant Ovarian Cancer (NCT02431559) | Ludwig Institute for Cancer Research | 2015-12-02 |
| Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients (NCT02622932) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2015-12-02 |
| CD19 Chimeric Antigen Receptor (CAR)-Modified T Cell Therapy in Treating Patients With B-cell Malignancies (NCT02965092) | Wuhan Sian Medical Technology Co., Ltd | 2015-12-02 |
| Leflunomide in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT02509052) | City of Hope Medical Center | 2015-12-02 |
| Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment (NCT02578082) | Mylan Inc. | 2015-12-01 |
| Safety Study of CN-105 Neuroprotective Peptide for Intracerebral Hemorrhage (NCT02670824) | AegisCN LLC | 2015-12-01 |
| A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults (NCT02633839) | Acorda Therapeutics | 2015-12-01 |
| Study to Evaluate Safety, Tolerability, and Pharmacokinetics of UB-621 in Healthy Volunteers (NCT02346760) | United BioPharma | 2015-12-01 |
| Clinical Trial of Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells Therapy for Knee Osteoarthritis (NCT02641860) | Shanghai AbelZeta Ltd. | 2015-12-01 |
| Targeting Microenvironment and Cellular Immunity in Sarcomas Weekly Trabectedin Combined With Metronomic Cyclophosphamide (NCT02805725) | Institut Bergonié | 2015-12-01 |
| Exploratory Study To Assess the Efficacy and Safety of a Triple Combination for Acute Pain Treatment in Patients With Temporomandibular Joint Disorders (TMJD). (NCT02602483) | Spherium Biomed | 2015-12-01 |
| Study of AZD6738, DNA Damage Repair/Novel Anti-cancer Agent, in Combination With Paclitaxel, in Refractory Cancer (NCT02630199) | Samsung Medical Center | 2015-12-01 |
| Study of Monalizumab and Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT02643550) | Innate Pharma | 2015-12-01 |
| BPN14770 Single Ascending Dose Study in Healthy Male and Female Subjects (NCT02648672) | Tetra Discovery Partners | 2015-12-01 |
| A Study of Anthrax Vaccines Px563L and RPA563 in Healthy Adult Subjects (NCT02655549) | Pfenex, Inc | 2015-12-01 |
| Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILI (NCT02651350) | Beijing 302 Hospital | 2015-12-01 |
| A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder (NCT02636842) | Alkermes, Inc. | 2015-12-01 |
| Bioequivalence Study of Tetrabenazine Tablets 25 mg Under Fed Conditions (NCT03702855) | Dr. Reddy's Laboratories Limited | 2015-12-01 |
| Resveratrol and Human Hepatocyte Function in Cancer (NCT02261844) | University of Louisville | 2015-12-01 |
| Pharmacokinetics of FDL169 in Healthy Female Subjects (NCT02680418) | Flatley Discovery Lab LLC | 2015-12-01 |
| Safety, Tolerability and Pharmacokinetics Study of AIR DNAse Administered by Inhalation to Healthy Adult Volunteers (NCT02605590) | Protalix | 2015-12-01 |
| Tamoxifen in Patients With Oesophageal Cancer (NCT02513849) | University of Nottingham | 2015-12-01 |
| CAR-T Cell Therapy Targeting to CD19 for R/R ALL (NCT03919240) | The First Affiliated Hospital of Soochow University | 2015-12-01 |
| Sulforaphane Treatment of Children With Autism Spectrum Disorder (ASD) (NCT02561481) | University of Massachusetts, Worcester | 2015-12-01 |
| A Study to Assess the Relative Oral Bioavailability of JNJ-63623872 Administered as Oral Concept Formulations Compared to the Current Tablet Formulation (NCT02659735) | Janssen Research & Development, LLC | 2015-12-01 |
| Safety and Immunogenicity Study of Live Attenuated Vaccine Against Herpes Zoster in Chinese Adults Aged 50 Years and Older (NCT02526745) | Beijing Chaoyang District Centre for Disease Control and Prevention | 2015-12-01 |
| Nesiritide in Hypertension (NCT02608996) | Oslo University Hospital | 2015-12-01 |
| Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects (NCT03076385) | ModernaTX, Inc. | 2015-12-01 |
| Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer. (NCT02598687) | Maastricht Radiation Oncology | 2015-12-01 |
| The REACT-ICD Trial (NCT02439424) | Hartford Hospital | 2015-12-01 |
| SASS 2 : Self Assembled Skin Substitute for the Autologous Treatment of Severe Burn Wounds in Acute Stage of Burn Trauma (NCT02350205) | CHU de Quebec-Universite Laval | 2015-12-01 |
| Study of Pharmacodynamic Effects of VAY736 in Patients With Primary Sjögren's Syndrome (NCT02495129) | Novartis Pharmaceuticals | 2015-12-01 |
| Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph ) (NCT02686216) | Chang Gung Memorial Hospital | 2015-12-01 |
| A Comparison Study of PF708 and Forteo in Healthy Subjects (NCT02656810) | Pfenex, Inc | 2015-12-01 |
| Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma (NCT02620423) | Oncolytics Biotech | 2015-12-01 |
| Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma (NCT02639767) | Memorial Sloan Kettering Cancer Center | 2015-12-01 |
| Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals (NCT02649062) | NGM Biopharmaceuticals, Inc | 2015-12-01 |
| A Dose Escalation Trial of Stereotactic Body Radiotherapy (SBRT) After Induction Chemotherapy for Locally Advanced Pancreatic Cancer (NCT02643498) | Memorial Sloan Kettering Cancer Center | 2015-12-01 |
| Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK) (NCT02675127) | Genuine Research Center, Egypt | 2015-12-01 |
| Study Comparing Pharmacokinetics, Safety and Immunogenicity of CT-P6 and US-licensed Herceptin (NCT02665637) | Celltrion | 2015-12-01 |
| A Study of Ibrutinib + Obinutuzumab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (NCT02537613) | Dana-Farber Cancer Institute | 2015-12-01 |
| Study of Ulipristal Acetate in Female Patients With Moderately or Severely Impaired Renal Function, Compared With Matched Healthy Female Subjects (NCT02634437) | Allergan | 2015-12-01 |
| Safety and Tolerability of hRPC in Retinitis Pigmentosa (NCT02464436) | ReNeuron Limited | 2015-12-01 |
| fMRI Study of Effects of Nasal Insulin on Memory (NCT02758691) | Virginia Polytechnic Institute and State University | 2015-12-01 |
| Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy Subjects (NCT02560688) | Daiichi Sankyo | 2015-12-01 |
| A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 (NCT02637531) | Infinity Pharmaceuticals, Inc. | 2015-12-01 |
| [11C]Cimbi-36 Dosimetry (NCT02629003) | Gitte Moos Knudsen | 2015-12-01 |
| Fecal Microbiome Transplant (NCT02636517) | Judith Kelsen | 2015-12-01 |
| Memory-enriched CAR-T Cells Immunotherapy for B Cell Lymphoma (NCT02652910) | Xinqiao Hospital of Chongqing | 2015-12-01 |
| "First-in-human" Study To Assess the Safety and Tolerability of PBF-677 in Healthy Volunteers (NCT02639975) | Palobiofarma SL | 2015-12-01 |
| Hierarchical Treatment Based on Somatization Symptom Checklist (NCT02723903) | RenJi Hospital | 2015-12-01 |
| Study to Assess the Food Effect on the Pharmacokinetics of Nifurtimox Tablets in Chronic Chagas' Patients (NCT02606864) | Bayer | 2015-12-01 |
| Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) (NCT02021526) | Juan Pascual | 2015-12-01 |
| First in Man Clinical Trial of Emodepside (BAY 44-4400) (NCT02661178) | Drugs for Neglected Diseases | 2015-12-01 |
| Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors (NCT02537561) | Washington University School of Medicine | 2015-12-01 |
| Food Effect Study PF-04136309 (NCT02598206) | Pfizer | 2015-12-01 |
| A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of Escalating Doses of SAR438544 in Comparison to Placebo and Glucagon in Healthy Subjects and Type 1 Diabetes Mellitus Patients (NCT02625636) | Sanofi | 2015-12-01 |
| A Study to Evaluate Pain, Tolerability, Safety, and Usability of a Single Self-administered Etrolizumab by Auto-injector in Healthy Participants (NCT02629744) | Genentech, Inc. | 2015-12-01 |
| Safety Study of Cenderitide in Chronic Stable Heart Failure With Moderate Renal Impairment (NCT02603614) | Capricor Inc. | 2015-12-01 |
| Safety & Efficacy of Lamivudine & Tenofovir to Lower Plasma Level of Viral RNA in Lymphoma (NCT01528865) | University of Michigan Rogel Cancer Center | 2015-12-01 |
| Cancer Stem Cell High-Throughput Drug Screening Study (NCT02654964) | Swedish Medical Center | 2015-12-01 |
| Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF (NCT02626182) | National Jewish Health | 2015-12-01 |
| Study to Evaluate SPI-1005 in Adults With Meniere's Disease (NCT02603081) | Sound Pharmaceuticals, Incorporated | 2015-12-01 |
| A Safety and Tolerability Study of AG-519 in Healthy Subjects (NCT02630927) | Agios Pharmaceuticals, Inc. | 2015-12-01 |